Total error in lymphocyte subpopulations by flow cytometry-based in state of the art using Spanish EQAS data

Author:

Comins-Boo Alejandra1ORCID,Pérez-Pla Fernando1,Irure-Ventura Juan1ORCID,López-Hoyos Marcos1ORCID,Blanco-Peris Lydia2,Martín Alonso María del Carmen2,San Segundo Arribas David1ORCID

Affiliation:

1. Immunology Department, Immunopathology Group , Marqués de Valdecilla University Hospital-IDIVAL , Santander , Spain

2. Centro de Hemoterapia y Hemodonación de Castilla y León , Valladolid , Spain

Abstract

Abstract Objectives Flow cytometry analyses of lymphocyte subpopulations (T, B, NK) are crucial for enhancing clinical algorithms and research workflows. Estimating the total error (TE) values for the percentage and absolute number of lymphocyte subpopulations using the state-of-the-art (SOTA) approach with real data from an external proficiency testing (EPT) scheme was performed. A comparison with previously published Biological Variability (BV)-based specifications was carried out. Methods A total of 44,998 results from 86 laboratories over 10 years were analysed and divided into two five-year periods (2012–2016) and (2017–2021). Data come from the IC-1 Lymphocytes scheme of the Spanish External Quality Assurance System (EQAS) GECLID Program. This quantitative scheme includes percentages and absolute numbers of CD3+, CD3+CD4+, CD3+CD8+, CD19+, and CD3CD56+CD16+ NK cells. The percentage of TE was calculated as: |reported value − robust mean|*100/robust mean for each laboratory and parameter. The cut-off for TE is set at 80 % best results of the laboratories. Results A significant reduction in the SOTA-based TE for all lymphocyte subpopulations in 2017–2021 was observed compared to 2012–2016. The SOTA-based TE fulfils the minimum BV-based TE for percentages of lymphocyte subpopulations. The parameter with the best analytical performance calculated with SOTA (2017–2021 period)-based TE was the percentage of CD3+ (TE=3.65 %). Conclusions The values of SOTA-based specifications from external quality assurance program data are consistent and can be used to develop technical specifications. The technological improvement, quality commitment, standardization, and training, reduce TE. An update of TE every five years is therefore recommended. TE assessment in lymphocyte subsets is a helpful and reliable tool to improve laboratory performance and data-based decision-making trust.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Reference34 articles.

1. The European Parliament and the Council of the European Union. REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. 2017.

2. ISO 15189:2022(es) Laboratorios clínicos. 2022.

3. World Health Organization (WHO). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy [Internet]; 2017. https://www.who.int/publications/i/item/9789241550062 [Accessed 30 Jun 2023].

4. World Health Organization (WHO). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach [Internet]; 2021. https://www.who.int/publications/i/item/9789240031593 [Accessed 30 Jun 2023].

5. European AIDS Clinical Society. EACS Guidelines. 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3